Sahajanand Medical Technologies’ IPO enters its final bidding day with 82% subscription on Day 2 and a 7% grey market premium. The Rs 475.48 crore offer is entirely an offer for sale. Investors will monitor subscription trends, listing expectations and strong FY26 profit growth before the shares debut.
Sahajanand Medical Technologies’ IPO enters its final bidding day with 82% subscription on Day 2 and a 7% grey market premium. The Rs 475.48 crore offer is entirely an offer for sale. Investors will monitor subscription trends, listing expectations and strong FY26 profit growth before the shares debut.
<iframe src="https://hindustansphere.com/embed/cluster/3051d637011c9fb12741d7cd91ef62d85cfb8be3" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Sahajanand Medical Technologies IPO Day 3: GMP at 7%; check subscription status and key details"></iframe>
Sahajanand Medical Technologies IPO entered Day 2 on October 16, 2026, with a 12% GMP and 34% subscription on Day 1. The Rs 475.48-crore offer for sale is priced at Rs 327-344 per share. PAT surged 175% to Rs 69 crore in FY26 amid steady revenue growth.
